A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06604715 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06604715
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2027-11-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.